Foluso Olabisi Ademuyiwa, MD, MPH, MSCI

Foluso Olabisi Ademuyiwa, MD, MPH, MSCI

Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology, Washington University School of Medicine

Clinical Expertise

Breast cancer, medical oncology

Research Interest

Breast cancer clinical trials, triple negative breast cancer, early-onset breast cancer, racial disparities.

Education

  • 1999: MD, University of Ibadan, Ibadan, Nigeria
  • 2001: MPH, Johns Hopkins University, Baltimore
  • 2016: MSCI, Washington University, St. Louis

Training

  • 1999 - 2000: Intern, University College Hospital, Ibadan, Nigeria
  • 2002 - 2006: Resident and chief resident, medicine and pediatrics, Bridgeport Hospital/Yale New Haven Health, Bridgeport, Conn.
  • 2006 - 2009: Fellow, hematology/oncology, Indiana University, Indianapolis

Board Certification

  • 2006: American Board of Internal Medicine, Internal Medicine
  • 2006: American Board of Pediatrics, General Pediatrics
  • 2009: American Board of Internal Medicine, Medical Oncology

Selected Research Publications

Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
  • Hensing WL, Gerratana L, Clifton K, [...] Ademuyiwa FO, [...] Davis AA
  • Clin Cancer Res 2023
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.
  • Davis AA, Gerratana L, Clifton K, [...] Ademuyiwa FO, [...] Cristofanilli M
  • EBioMedicine 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
  • Anurag M, Jaehnig EJ, Krug K, [...] Ademuyiwa FO, [...] Ellis MJ
  • Cancer Discov 2022
Call for action: expanding global access to hereditary cancer genetic testing.
  • Bychkovsky B, Rana HQ, Ademuyiwa F, [...] Dizon DS
  • Lancet Oncol 2022
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
  • Roy S, Whitehead TD, Li S, Ademuyiwa FO, [...] Shoghi KI
  • Eur J Nucl Med Mol Imaging 2022
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.
  • Bagegni NA, Davis AA, Clifton KK, Ademuyiwa FO
  • Breast Cancer (Dove Med Press) 2022

View All Publications

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

  • South St. Louis County

    5225 Midamerica Plaza
    St. Louis, MO 63129

Phone Numbers

Request an appointment